Drug-resistant super-flu threatens hospital patients

A new flu virus emerging in the Netherlands and the U.S. could pose a serious risk to patients with weak immune systems, as it is resistant to anti-viral drugs. Marketed as Tamiflu, the drug is used to protect particularly those most vulnerable to the flu. The research presented by scientists is highlighted in the Journal of the American Medical Association.